Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation

Transplant Immunology

Volumn 30, Issue 1, 2014, Pages 1-6

  Hirt Minkowski, Patricia ^a   Marti, Hans Peter ^b,c   Hönger, Gideon ^a   Grandgirard, Denis ^d   Leib, Stephen L ^d,e   Amico, Patrizia ^a   Schaub, Stefan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERN   (Switzerland)

^e SPIEZ LABORATORY   (Switzerland)

Author keywords

Interstitial fibrosis and tubular atrophy; Matrix metalloproteases; Non invasive monitoring; Renal transplantation; Tissue inhibitors of metalloproteases

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; INFLAMMATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE DISORDER; MALE; MATRIX METALLOPROTEINASE BLOOD LEVEL; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGRESSIVE INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY; PROTEIN BLOOD LEVEL; RENAL GRAFT DYSFUNCTION; SUBCLINICAL TUBULITIS; TISSUE INHIBITOR OF METALLOPROTEINASE BLOOD LEVEL; ALLOGRAFT; ASYMPTOMATIC DISEASE; ATROPHY; BLOOD; FIBROSIS; FOLLOW UP; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGIC MONITORING; PROGNOSIS; URINE;

ADULT; ALLOGRAFTS; ASYMPTOMATIC DISEASES; ATROPHY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84891836372     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.11.004     Document Type: Article

References (24)

1. Chapman J.R., O'Connell P.J., Nankivell B.J. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005, 16:3015-3026.
2. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004, 78:242-249.
3. Nankivell B.J., Fenton-Lee C.A., Kuypers D.R., et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001, 71:515-523.
4. El-Zoghby Z.M., Stegall M.D., Lager D.J., et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009, 9:527-535.
5. Park W.D., Griffin M.D., Cornell L.D., Cosio F.G., Stegall M.D. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010, 21:1987-1997.
6. Waller J.R., Nicholson M.L. Molecular mechanisms of renal allograft fibrosis. Br J Surg 2001, 88:1429-1441.
7. Eddy A.A. Molecular basis of renal fibrosis. Pediatr Nephrol 2000, 15:290-301.
8. Stocker W., Bode W. Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struct Biol 1995, 5:383-390.
9. Stocker W., Grams F., Baumann U., et al. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995, 4:823-840.
10. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
11. Mannon R.B. Therapeutic targets in the treatment of allograft fibrosis. Am J Transplant 2006, 6:867-875.
12. Tan R.J., Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol 2012, 302:F1351-F1361.
13. Catania J.M., Chen G., Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007, 292:F905-F911.
14. Rodder S., Scherer A., Korner M., Marti H.P. A subset of metzincins and related genes constitutes a marker of human solid organ fibrosis. Virchows Arch 2011, 458:487-496.
15. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
16. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-2154.
17. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003, 200:448-464.
18. Wilson C.L., Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996, 28:123-136.
19. Moore C.S., Crocker S.J. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 2012, 180:12-16.
20. Rodder S., Scherer A., Raulf F., et al. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009, 9:517-526.
21. Sis B., Mengel M., Haas M., et al. Banff '09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups. Am J Transplant 2010, 10:464-471.
22. Kitajima K., Koike J., Nozawa S., Yoshiike M., Takagi M., Chikaraishi T. Irreversible immunoexpression of matrix metalloproteinase-9 in proximal tubular epithelium of renal allografts with acute rejection. Clin Transplant 2011, 25:E336-E344.
23. Rodder S., Scherer A., Korner M., et al. Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients. Am J Transplant 2010, 10:286-297.
24. Mengel M., Bock O., Priess M., Haller H., Kreipe H., Gwinner W. Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy. Clin Nephrol 2008, 69:408-416.